Cargando…
Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857674/ https://www.ncbi.nlm.nih.gov/pubmed/29532792 http://dx.doi.org/10.1038/ncomms16187 |
| _version_ | 1783307512247746560 |
|---|---|
| author | Cook, Peter J. Thomas, Rozario Kannan, Ram de Leon, Esther Sanchez Drilon, Alexander Rosenblum, Marc K. Scaltriti, Maurizio Benezra, Robert Ventura, Andrea |
| author_facet | Cook, Peter J. Thomas, Rozario Kannan, Ram de Leon, Esther Sanchez Drilon, Alexander Rosenblum, Marc K. Scaltriti, Maurizio Benezra, Robert Ventura, Andrea |
| author_sort | Cook, Peter J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5857674 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-58576742018-03-20 Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target Cook, Peter J. Thomas, Rozario Kannan, Ram de Leon, Esther Sanchez Drilon, Alexander Rosenblum, Marc K. Scaltriti, Maurizio Benezra, Robert Ventura, Andrea Nat Commun Correction Nature Publishing Group 2018-03-13 /pmc/articles/PMC5857674/ /pubmed/29532792 http://dx.doi.org/10.1038/ncomms16187 Text en Copyright © 2018, The Author(s) http://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Correction Cook, Peter J. Thomas, Rozario Kannan, Ram de Leon, Esther Sanchez Drilon, Alexander Rosenblum, Marc K. Scaltriti, Maurizio Benezra, Robert Ventura, Andrea Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target |
| title | Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target |
| title_full | Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target |
| title_fullStr | Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target |
| title_full_unstemmed | Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target |
| title_short | Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target |
| title_sort | author correction: somatic chromosomal engineering identifies bcan-ntrk1 as a potent glioma driver and therapeutic target |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857674/ https://www.ncbi.nlm.nih.gov/pubmed/29532792 http://dx.doi.org/10.1038/ncomms16187 |
| work_keys_str_mv | AT cookpeterj authorcorrectionsomaticchromosomalengineeringidentifiesbcanntrk1asapotentgliomadriverandtherapeutictarget AT thomasrozario authorcorrectionsomaticchromosomalengineeringidentifiesbcanntrk1asapotentgliomadriverandtherapeutictarget AT kannanram authorcorrectionsomaticchromosomalengineeringidentifiesbcanntrk1asapotentgliomadriverandtherapeutictarget AT deleonesthersanchez authorcorrectionsomaticchromosomalengineeringidentifiesbcanntrk1asapotentgliomadriverandtherapeutictarget AT drilonalexander authorcorrectionsomaticchromosomalengineeringidentifiesbcanntrk1asapotentgliomadriverandtherapeutictarget AT rosenblummarck authorcorrectionsomaticchromosomalengineeringidentifiesbcanntrk1asapotentgliomadriverandtherapeutictarget AT scaltritimaurizio authorcorrectionsomaticchromosomalengineeringidentifiesbcanntrk1asapotentgliomadriverandtherapeutictarget AT benezrarobert authorcorrectionsomaticchromosomalengineeringidentifiesbcanntrk1asapotentgliomadriverandtherapeutictarget AT venturaandrea authorcorrectionsomaticchromosomalengineeringidentifiesbcanntrk1asapotentgliomadriverandtherapeutictarget |